Skip to main content
Fig. 5 | Molecular Neurodegeneration

Fig. 5

From: Tau PET imaging: present and future directions

Fig. 5

In vivo imaging of AD biomarkers in a patient with prodromal AD and in a patient with AD dementia. The retention of [18F]THK5317 and [11C]PIB are expressed with reference to the retention in the grey matter of the cerebellum; [18F]FDG uptake is expressed with reference to uptake in the pons. AD = Alzheimer’s disease; DVR = distribution volume ratio; FDG = fluorodeoxyglucose; PIB = Pittsburgh compound B; SUVR = standardized uptake value ratio

Back to article page

Molecular Neurodegeneration

ISSN: 1750-1326